| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 9.92e-10 | 17 | 259 | 7 | GO:0005132 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.12e-05 | 5 | 259 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 3.25e-05 | 29 | 259 | 5 | GO:0045499 | |
| GeneOntologyMolecularFunction | endopeptidase activity | USP34 PMPCA HPN TMPRSS7 MMP16 MMP19 KLK15 PAPPA2 CAPNS1 NLRP1 PRSS33 ADAM22 TLL2 CORIN ADAMTS14 ECE2 | 1.68e-04 | 430 | 259 | 16 | GO:0004175 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.73e-04 | 120 | 259 | 8 | GO:0004222 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 2.02e-04 | 23 | 259 | 4 | GO:0030215 | |
| GeneOntologyMolecularFunction | peptidase activity | USP34 GGH PMPCA HPN TMPRSS7 MMP16 MMP19 KLK15 PAPPA2 CAPNS1 CPA1 NLRP1 PRSS33 ADAM22 DPP9 TLL2 CORIN USP54 ADAMTS14 ECE2 | 3.64e-04 | 654 | 259 | 20 | GO:0008233 |
| GeneOntologyMolecularFunction | diacylglycerol cholinephosphotransferase activity | 4.98e-04 | 3 | 259 | 2 | GO:0004142 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 4.31e-09 | 21 | 257 | 7 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 1.24e-08 | 24 | 257 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 4.07e-08 | 28 | 257 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 3.82e-07 | 55 | 257 | 8 | GO:0043330 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 7.99e-07 | 42 | 257 | 7 | GO:0002323 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 1.12e-06 | 63 | 257 | 8 | GO:0043331 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 1.14e-06 | 85 | 257 | 9 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 1.25e-06 | 86 | 257 | 9 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.85e-06 | 90 | 257 | 9 | GO:0098586 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 2.22e-06 | 92 | 257 | 9 | GO:0034340 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 1.13e-05 | 112 | 257 | 9 | GO:0140888 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.31e-05 | 63 | 257 | 7 | GO:0050691 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.67e-05 | 90 | 257 | 8 | GO:0050688 | |
| GeneOntologyBiologicalProcess | CDP-choline pathway | 6.45e-05 | 7 | 257 | 3 | GO:0006657 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | ITFG2 RC3H2 CR1 IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 MSH6 PRKCZ | 7.82e-05 | 251 | 257 | 12 | GO:0002285 |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.02e-04 | 148 | 257 | 9 | GO:0002286 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 1.55e-04 | 2 | 257 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.65e-04 | 124 | 257 | 8 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | PELI3 IRAK1 ADAR TRIL TRAFD1 NFKBIA WASHC4 NLRP1 GRN CR1 IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 TRIM62 CD37 TRAF3IP3 | 1.74e-04 | 643 | 257 | 20 | GO:0002831 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ETV4 MCF2 SLIT2 DACT1 SEMA5B IGSF9 CNP KIF13B SEMA7A SYNE1 FAT3 L1CAM BRSK2 LAMA2 LAMB2 CRPPA SEMA5A LMO4 TSKU BRSK1 MAPK8IP2 SEMA3E | 1.82e-04 | 748 | 257 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ETV4 MCF2 SLIT2 DACT1 SEMA5B ARHGEF7 IGSF9 CNP KIF13B SEMA7A SYNE1 L1CAM BRSK2 LAMA2 LAMB2 CRPPA SEMA5A LMO4 TSKU PRKCZ BRSK1 MAPK8IP2 SEMA3E | 2.53e-04 | 819 | 257 | 23 | GO:0120039 |
| GeneOntologyBiologicalProcess | axon guidance | ETV4 SLIT2 SEMA5B IGSF9 SEMA7A L1CAM LAMA2 LAMB2 CRPPA SEMA5A LMO4 SEMA3E | 2.56e-04 | 285 | 257 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | ETV4 SLIT2 SEMA5B IGSF9 SEMA7A L1CAM LAMA2 LAMB2 CRPPA SEMA5A LMO4 SEMA3E | 2.64e-04 | 286 | 257 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 2.73e-04 | 101 | 257 | 7 | GO:0033138 | |
| GeneOntologyBiologicalProcess | axonogenesis | ETV4 MCF2 SLIT2 SEMA5B IGSF9 CNP KIF13B SEMA7A L1CAM BRSK2 LAMA2 LAMB2 CRPPA SEMA5A LMO4 TSKU BRSK1 SEMA3E | 2.81e-04 | 566 | 257 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ETV4 MCF2 SLIT2 DACT1 SEMA5B ARHGEF7 IGSF9 CNP KIF13B SEMA7A SYNE1 L1CAM BRSK2 LAMA2 LAMB2 CRPPA SEMA5A LMO4 TSKU PRKCZ BRSK1 MAPK8IP2 SEMA3E | 2.86e-04 | 826 | 257 | 23 | GO:0048858 |
| GeneOntologyBiologicalProcess | response to virus | ADAR DMBT1 NLRP1 VWCE IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 MST1R CD37 EXOC1 TRAF3IP3 | 3.07e-04 | 425 | 257 | 15 | GO:0009615 |
| GeneOntologyBiologicalProcess | defense response to virus | ADAR DMBT1 NLRP1 IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 CD37 EXOC1 TRAF3IP3 | 3.84e-04 | 342 | 257 | 13 | GO:0051607 |
| GeneOntologyBiologicalProcess | detection of light stimulus | 4.00e-04 | 77 | 257 | 6 | GO:0009583 | |
| GeneOntologyCellularComponent | extracellular matrix | SPOCK2 SVEP1 TRIL SLIT2 FREM2 FBN2 FGF1 DMBT1 MMP16 USH2A MMP19 ZAN SEMA7A L1CAM LAMA2 LAMB2 MUC5B IFNA2 TSKU LOX FGFBP3 ADAMTS14 | 2.64e-05 | 656 | 260 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SPOCK2 SVEP1 TRIL SLIT2 FREM2 FBN2 FGF1 DMBT1 MMP16 USH2A MMP19 ZAN SEMA7A L1CAM LAMA2 LAMB2 MUC5B IFNA2 TSKU LOX FGFBP3 ADAMTS14 | 2.76e-05 | 658 | 260 | 22 | GO:0030312 |
| Domain | Interferon | 1.57e-09 | 17 | 259 | 7 | PF00143 | |
| Domain | INTERFERON_A_B_D | 1.57e-09 | 17 | 259 | 7 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 1.57e-09 | 17 | 259 | 7 | IPR000471 | |
| Domain | IFabd | 1.57e-09 | 17 | 259 | 7 | SM00076 | |
| Domain | ConA-like_dom | CMYA5 SVEP1 SLIT2 USH2A TRIM60 PAPPA2 ZAN FAT3 LAMA2 MAMDC4 LGALS2 TRIM10 TRIM62 WDFY3 TRIM47 | 4.34e-07 | 219 | 259 | 15 | IPR013320 |
| Domain | EGF_1 | SVEP1 SLIT2 FBN2 NTN5 UMOD USH2A ZAN FAT3 LAMA2 LAMB2 CUBN VWCE ADAM22 HHIP TLL2 | 2.93e-06 | 255 | 259 | 15 | PS00022 |
| Domain | - | 5.46e-06 | 50 | 259 | 7 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 6.26e-06 | 51 | 259 | 7 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | 8.39e-06 | 74 | 259 | 8 | IPR009079 | |
| Domain | EGF_2 | SVEP1 SLIT2 FBN2 NTN5 UMOD ZAN FAT3 LAMA2 LAMB2 CUBN VWCE ADAM22 HHIP TLL2 | 2.12e-05 | 265 | 259 | 14 | PS01186 |
| Domain | EGF | SVEP1 SLIT2 FBN2 UMOD ZAN FAT3 LAMA2 LAMB2 CUBN VWCE ADAM22 HHIP TLL2 | 2.59e-05 | 235 | 259 | 13 | SM00181 |
| Domain | FN3_dom | OBSCN CMYA5 TRIL PTPRG IGSF9 RIMBP3C USH2A PAPPA2 L1CAM IGDCC4 RIMBP3 RIMBP3B | 3.69e-05 | 209 | 259 | 12 | IPR003961 |
| Domain | EGF-like_dom | SVEP1 SLIT2 FBN2 UMOD ZAN FAT3 LAMA2 LAMB2 CUBN VWCE ADAM22 HHIP TLL2 | 4.72e-05 | 249 | 259 | 13 | IPR000742 |
| Domain | - | 5.27e-05 | 95 | 259 | 8 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 6.12e-05 | 97 | 259 | 8 | IPR018097 | |
| Domain | Semap_dom | 6.24e-05 | 31 | 259 | 5 | IPR001627 | |
| Domain | SEMA | 6.24e-05 | 31 | 259 | 5 | PS51004 | |
| Domain | Sema | 6.24e-05 | 31 | 259 | 5 | SM00630 | |
| Domain | Sema | 6.24e-05 | 31 | 259 | 5 | PF01403 | |
| Domain | EGF_CA | 7.08e-05 | 99 | 259 | 8 | PS01187 | |
| Domain | EGF-like_CS | SVEP1 SLIT2 FBN2 UMOD ZAN FAT3 LAMA2 LAMB2 CUBN VWCE ADAM22 HHIP TLL2 | 7.63e-05 | 261 | 259 | 13 | IPR013032 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.15e-04 | 106 | 259 | 8 | IPR000152 | |
| Domain | - | 1.32e-04 | 81 | 259 | 7 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 1.32e-04 | 81 | 259 | 7 | IPR024079 | |
| Domain | Semaphorin | 1.47e-04 | 20 | 259 | 4 | IPR027231 | |
| Domain | EGF_CA | 1.92e-04 | 86 | 259 | 7 | PF07645 | |
| Domain | FN3 | OBSCN CMYA5 PTPRG IGSF9 RIMBP3C USH2A PAPPA2 L1CAM IGDCC4 RIMBP3B | 2.67e-04 | 185 | 259 | 10 | SM00060 |
| Domain | EGF_CA | 3.03e-04 | 122 | 259 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.38e-04 | 124 | 259 | 8 | IPR001881 | |
| Domain | PSI | 3.44e-04 | 44 | 259 | 5 | IPR016201 | |
| Domain | SR | 3.63e-04 | 25 | 259 | 4 | SM00202 | |
| Domain | - | OBSCN SIGLEC5 CMYA5 IGSF10 PTPRG ALPK3 IGSF9 RIMBP3C ZPBP2 USH2A SIGLEC12 PAPPA2 SEMA7A L1CAM IGDCC4 RIMBP3 MST1R CEACAM16 GPCPD1 RIMBP3B SEMA3E | 3.92e-04 | 663 | 259 | 21 | 2.60.40.10 |
| Domain | SRCR-like_dom | 4.25e-04 | 26 | 259 | 4 | IPR017448 | |
| Domain | SRCR_1 | 4.25e-04 | 26 | 259 | 4 | PS00420 | |
| Domain | SRCR_2 | 4.25e-04 | 26 | 259 | 4 | PS50287 | |
| Domain | PSI | 4.25e-04 | 46 | 259 | 5 | SM00423 | |
| Domain | ZINC_PROTEASE | 4.30e-04 | 98 | 259 | 7 | PS00142 | |
| Domain | EGF_3 | 4.59e-04 | 235 | 259 | 11 | PS50026 | |
| Domain | FN3 | OBSCN CMYA5 PTPRG IGSF9 RIMBP3C USH2A L1CAM IGDCC4 RIMBP3 RIMBP3B | 4.77e-04 | 199 | 259 | 10 | PS50853 |
| Domain | ASX_HYDROXYL | 4.86e-04 | 100 | 259 | 7 | PS00010 | |
| Domain | SRCR | 4.93e-04 | 27 | 259 | 4 | IPR001190 | |
| Domain | CHOPT | 5.69e-04 | 3 | 259 | 2 | IPR014472 | |
| Domain | CUB | 5.72e-04 | 49 | 259 | 5 | PF00431 | |
| Domain | Kinase-like_dom | GAK CDK15 OBSCN IRAK1 CHKB MAST4 MYLK3 PI4KB ALPK3 RPS6KL1 AMHR2 BRSK2 ERN2 MST1R GUCY2D PRKCB PRKCZ BRSK1 | 5.91e-04 | 542 | 259 | 18 | IPR011009 |
| Domain | CUB | 6.28e-04 | 50 | 259 | 5 | SM00042 | |
| Domain | EGF_LAM_2 | 7.46e-04 | 30 | 259 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 7.46e-04 | 30 | 259 | 4 | PS01248 | |
| Domain | - | 7.53e-04 | 52 | 259 | 5 | 2.60.120.290 | |
| Domain | CUB | 8.23e-04 | 53 | 259 | 5 | PS01180 | |
| Domain | Ig-like_fold | OBSCN SIGLEC5 CMYA5 IGSF10 PTPRG ALPK3 IGSF9 RIMBP3C ZPBP2 USH2A SIGLEC12 PAPPA2 SEMA7A L1CAM IGDCC4 RIMBP3 MST1R CEACAM16 GPCPD1 RIMBP3B SEMA3E | 8.81e-04 | 706 | 259 | 21 | IPR013783 |
| Domain | SNF2_N | 9.57e-04 | 32 | 259 | 4 | IPR000330 | |
| Domain | SNF2_N | 9.57e-04 | 32 | 259 | 4 | PF00176 | |
| Domain | Plexin_repeat | 9.57e-04 | 32 | 259 | 4 | IPR002165 | |
| Domain | PSI | 9.57e-04 | 32 | 259 | 4 | PF01437 | |
| Domain | Kinesin-like_KIF1-typ | 1.13e-03 | 4 | 259 | 2 | IPR022140 | |
| Domain | LamGL | 1.13e-03 | 4 | 259 | 2 | SM00560 | |
| Domain | KIF1B | 1.13e-03 | 4 | 259 | 2 | PF12423 | |
| Domain | LamG-like | 1.13e-03 | 4 | 259 | 2 | IPR006558 | |
| Domain | CUB_dom | 1.15e-03 | 57 | 259 | 5 | IPR000859 | |
| Domain | RING | CHD3 DTX2 TRIM60 UBR2 RC3H2 MEX3D TRIM10 RNF151 KMT2D TRIM62 TRIM47 SH3RF3 | 1.19e-03 | 305 | 259 | 12 | SM00184 |
| Domain | Laminin_N | 1.29e-03 | 16 | 259 | 3 | IPR008211 | |
| Domain | LamNT | 1.29e-03 | 16 | 259 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 1.29e-03 | 16 | 259 | 3 | PS51117 | |
| Domain | Laminin_N | 1.29e-03 | 16 | 259 | 3 | PF00055 | |
| Domain | EGF_Lam | 1.35e-03 | 35 | 259 | 4 | SM00180 | |
| Domain | Laminin_EGF | 1.35e-03 | 35 | 259 | 4 | PF00053 | |
| Domain | Ser/Thr_kinase_AS | GAK CDK15 OBSCN IRAK1 MAST4 MYLK3 RPS6KL1 AMHR2 BRSK2 ERN2 PRKCB PRKCZ BRSK1 | 1.51e-03 | 357 | 259 | 13 | IPR008271 |
| Domain | - | KMT2B CHD3 DTX2 TRIM60 UBR2 RC3H2 MEX3D ZNF521 TRIM10 RNF151 KMT2D TRIM62 WDFY3 TRIM47 SH3RF3 | 1.58e-03 | 449 | 259 | 15 | 3.30.40.10 |
| Domain | PROTEIN_KINASE_ST | GAK CDK15 OBSCN IRAK1 MAST4 MYLK3 RPS6KL1 AMHR2 BRSK2 ERN2 PRKCB PRKCZ BRSK1 | 1.71e-03 | 362 | 259 | 13 | PS00108 |
| Domain | PH | KIF1B OBSCN MCF2 PLEKHN1 PLEKHM1 PLEKHH1 ARHGEF7 PSD2 SH2B1 IRS2 ARHGEF2 | 1.80e-03 | 278 | 259 | 11 | SM00233 |
| Domain | LAM_G_DOMAIN | 1.84e-03 | 38 | 259 | 4 | PS50025 | |
| Domain | Laminin_EGF | 1.84e-03 | 38 | 259 | 4 | IPR002049 | |
| Domain | PH_DOMAIN | KIF1B OBSCN MCF2 PLEKHN1 PLEKHM1 PLEKHH1 ARHGEF7 PSD2 SH2B1 IRS2 ARHGEF2 | 1.85e-03 | 279 | 259 | 11 | PS50003 |
| Domain | FYrich_C | 1.86e-03 | 5 | 259 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.86e-03 | 5 | 259 | 2 | IPR003888 | |
| Domain | FYRC | 1.86e-03 | 5 | 259 | 2 | SM00542 | |
| Domain | FYRN | 1.86e-03 | 5 | 259 | 2 | SM00541 | |
| Domain | TMEM132D_N | 1.86e-03 | 5 | 259 | 2 | PF15705 | |
| Domain | TMEM132D_C | 1.86e-03 | 5 | 259 | 2 | PF15706 | |
| Domain | TMEM132_M | 1.86e-03 | 5 | 259 | 2 | IPR031437 | |
| Domain | TMEM132_C | 1.86e-03 | 5 | 259 | 2 | IPR031436 | |
| Domain | TMEM132_N | 1.86e-03 | 5 | 259 | 2 | IPR031435 | |
| Domain | TMEM132 | 1.86e-03 | 5 | 259 | 2 | IPR026307 | |
| Domain | CDP-OH_P_transf | 1.86e-03 | 5 | 259 | 2 | PF01066 | |
| Domain | CDP-OH_P_trans | 1.86e-03 | 5 | 259 | 2 | IPR000462 | |
| Domain | TMEM132 | 1.86e-03 | 5 | 259 | 2 | PF16070 | |
| Domain | DDE_Tnp_1_7 | 1.86e-03 | 5 | 259 | 2 | PF13843 | |
| Domain | FYRN | 1.86e-03 | 5 | 259 | 2 | PF05964 | |
| Domain | FYRC | 1.86e-03 | 5 | 259 | 2 | PF05965 | |
| Domain | FYRC | 1.86e-03 | 5 | 259 | 2 | PS51543 | |
| Domain | FYRN | 1.86e-03 | 5 | 259 | 2 | PS51542 | |
| Domain | PGBD | 1.86e-03 | 5 | 259 | 2 | IPR029526 | |
| Domain | CDP_ALCOHOL_P_TRANSF | 1.86e-03 | 5 | 259 | 2 | PS00379 | |
| Domain | PH_domain | KIF1B OBSCN MCF2 PLEKHN1 PLEKHM1 PLEKHH1 ARHGEF7 PSD2 SH2B1 IRS2 ARHGEF2 | 1.90e-03 | 280 | 259 | 11 | IPR001849 |
| Domain | Znf_RING/FYVE/PHD | KMT2B CHD3 DTX2 TRIM60 UBR2 RC3H2 MEX3D ZNF521 TRIM10 RNF151 KMT2D TRIM62 WDFY3 TRIM47 SH3RF3 | 1.95e-03 | 459 | 259 | 15 | IPR013083 |
| Domain | GDS_CDC24_CS | 2.03e-03 | 39 | 259 | 4 | IPR001331 | |
| Domain | Znf_RING | CHD3 DTX2 TRIM60 UBR2 RC3H2 MEX3D TRIM10 RNF151 KMT2D TRIM62 TRIM47 SH3RF3 | 2.07e-03 | 326 | 259 | 12 | IPR001841 |
| Domain | VWC_out | 2.17e-03 | 19 | 259 | 3 | SM00215 | |
| Domain | LDLR_class-A_CS | 2.23e-03 | 40 | 259 | 4 | IPR023415 | |
| Domain | Laminin_G_2 | 2.23e-03 | 40 | 259 | 4 | PF02210 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 9.47e-11 | 20 | 188 | 8 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 2.35e-10 | 22 | 188 | 8 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 2.35e-10 | 22 | 188 | 8 | M47616 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 1.17e-09 | 17 | 188 | 7 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 1.89e-09 | 18 | 188 | 7 | M47539 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.67e-09 | 41 | 188 | 9 | MM1493 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 2.95e-09 | 19 | 188 | 7 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 2.95e-09 | 19 | 188 | 7 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 6.66e-09 | 21 | 188 | 7 | M47909 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.37e-08 | 23 | 188 | 7 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 1.37e-08 | 23 | 188 | 7 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 1.92e-08 | 24 | 188 | 7 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 1.92e-08 | 24 | 188 | 7 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.92e-08 | 24 | 188 | 7 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.56e-08 | 26 | 188 | 7 | M982 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 4.13e-08 | 55 | 188 | 9 | M11844 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 6.27e-08 | 28 | 188 | 7 | MM1378 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.05e-07 | 30 | 188 | 7 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.35e-07 | 31 | 188 | 7 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.35e-07 | 31 | 188 | 7 | M47964 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 2.14e-07 | 33 | 188 | 7 | MM1379 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.66e-07 | 34 | 188 | 7 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 3.29e-07 | 35 | 188 | 7 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 3.29e-07 | 35 | 188 | 7 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 4.93e-07 | 37 | 188 | 7 | M39785 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 5.13e-07 | 73 | 188 | 9 | M39837 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 7.19e-07 | 39 | 188 | 7 | MM15914 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 2.27e-06 | 65 | 188 | 8 | M272 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 2.31e-06 | 87 | 188 | 9 | MM15915 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 4.48e-06 | 71 | 188 | 8 | M15913 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 5.41e-06 | 52 | 188 | 7 | M13103 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 8.68e-06 | 102 | 188 | 9 | M3261 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 9.11e-06 | 78 | 188 | 8 | M973 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 9.41e-06 | 103 | 188 | 9 | M39434 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.32e-05 | 82 | 188 | 8 | M1002 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | IRAK1 ADAR NFKBIA IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 | 1.39e-05 | 136 | 188 | 10 | M42547 |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | KIF1B KIF15 KIF13B IFNA2 IFNA4 SH2B1 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 | 1.74e-05 | 170 | 188 | 11 | M941 |
| Pathway | REACTOME_INTERFERON_SIGNALING | 9.63e-05 | 138 | 188 | 9 | MM15635 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.71e-04 | 88 | 188 | 7 | M16004 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.91e-04 | 151 | 188 | 9 | M39801 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 2.83e-04 | 126 | 188 | 8 | M45009 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.86e-04 | 68 | 188 | 6 | M27303 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.34e-04 | 98 | 188 | 7 | M48247 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 3.64e-04 | 26 | 188 | 4 | MM14584 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | FGF20 FGF1 LAMA2 LAMB2 HIF3A IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 IRS2 | 4.36e-04 | 326 | 188 | 13 | MM15917 |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 4.88e-04 | 28 | 188 | 4 | M684 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 4.98e-04 | 137 | 188 | 8 | M5669 | |
| Pathway | WP_KENNEDY_PATHWAY | 7.62e-04 | 14 | 188 | 3 | MM15980 | |
| Pathway | WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS | 7.62e-04 | 14 | 188 | 3 | M39620 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 7.62e-04 | 14 | 188 | 3 | MM15047 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 9.49e-04 | 85 | 188 | 6 | MM14746 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | ILF2 ADAR IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 TRIM10 IFNA21 TRIM62 | 1.10e-03 | 273 | 188 | 11 | M983 |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.12e-03 | 120 | 188 | 7 | M48233 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 1.56e-03 | 127 | 188 | 7 | M42533 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 1.63e-03 | 128 | 188 | 7 | M706 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 1.64e-03 | 18 | 188 | 3 | MM14724 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | ILF2 PELI3 IRAK1 ADAR NFKBIA DUSP7 IFNA2 IFNA4 SH2B1 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 IRS2 | 1.66e-03 | 472 | 188 | 15 | MM14539 |
| Pathway | REACTOME_SIGNALING_BY_MST1 | 1.72e-03 | 5 | 188 | 2 | M27744 | |
| Pathway | WP_IL1_SIGNALING_PATHWAY | 1.75e-03 | 39 | 188 | 4 | MM15996 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.75e-03 | 39 | 188 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.75e-03 | 39 | 188 | 4 | MM15165 | |
| Pubmed | 4.67e-13 | 11 | 267 | 7 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 4.67e-13 | 11 | 267 | 7 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 4.67e-13 | 11 | 267 | 7 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 4.67e-13 | 11 | 267 | 7 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 4.67e-13 | 11 | 267 | 7 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 4.67e-13 | 11 | 267 | 7 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 4.67e-13 | 11 | 267 | 7 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 4.67e-13 | 11 | 267 | 7 | 15795237 | |
| Pubmed | 4.67e-13 | 11 | 267 | 7 | 9794439 | ||
| Pubmed | 4.67e-13 | 11 | 267 | 7 | 25310498 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.11e-12 | 12 | 267 | 7 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.11e-12 | 12 | 267 | 7 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.11e-12 | 12 | 267 | 7 | 27988795 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.11e-12 | 12 | 267 | 7 | 17512142 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.11e-12 | 12 | 267 | 7 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 1.11e-12 | 12 | 267 | 7 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 1.11e-12 | 12 | 267 | 7 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 1.11e-12 | 12 | 267 | 7 | 32016282 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.11e-12 | 12 | 267 | 7 | 7684767 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 1.11e-12 | 12 | 267 | 7 | 26277892 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 1.11e-12 | 12 | 267 | 7 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.11e-12 | 12 | 267 | 7 | 16611902 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 30967261 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.11e-12 | 12 | 267 | 7 | 22912583 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 23747509 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 17434974 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.11e-12 | 12 | 267 | 7 | 3758677 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 19406830 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 8245849 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 22685550 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 3017340 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 1.11e-12 | 12 | 267 | 7 | 8304945 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.11e-12 | 12 | 267 | 7 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 1.11e-12 | 12 | 267 | 7 | 1422836 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.11e-12 | 12 | 267 | 7 | 7530016 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 17277125 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 1.11e-12 | 12 | 267 | 7 | 1360280 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 17451966 | ||
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 1.11e-12 | 12 | 267 | 7 | 8672140 | |
| Pubmed | 1.11e-12 | 12 | 267 | 7 | 7601556 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 2.40e-12 | 13 | 267 | 7 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 2.40e-12 | 13 | 267 | 7 | 2014240 | |
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 18005734 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 2.40e-12 | 13 | 267 | 7 | 6094686 | |
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 2993652 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 1655578 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 2471809 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 21263073 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 8438572 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 38660315 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 2.40e-12 | 13 | 267 | 7 | 23255800 | |
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 7523540 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 19635904 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 19706714 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 23804712 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 2.40e-12 | 13 | 267 | 7 | 3973562 | |
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 2.40e-12 | 13 | 267 | 7 | 2987810 | |
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 19130550 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 21469099 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 22739040 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 20065291 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 2.40e-12 | 13 | 267 | 7 | 9865497 | |
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 9181467 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 17723216 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 2.40e-12 | 13 | 267 | 7 | 18726328 | |
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 18572754 | ||
| Pubmed | 2.40e-12 | 13 | 267 | 7 | 15723075 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 22815848 | ||
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 4.76e-12 | 14 | 267 | 7 | 18981154 | |
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 19620305 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 4.76e-12 | 14 | 267 | 7 | 7526537 | |
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 19559726 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 15240719 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 16418394 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 18272764 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 11884139 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 19004943 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 4.76e-12 | 14 | 267 | 7 | 7654369 | |
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 4.76e-12 | 14 | 267 | 7 | 7532202 | |
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 4.76e-12 | 14 | 267 | 7 | 18200009 | |
| Pubmed | Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. | 4.76e-12 | 14 | 267 | 7 | 20566717 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 4.76e-12 | 14 | 267 | 7 | 17517919 | |
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 21383240 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 14983024 | ||
| Pubmed | 4.76e-12 | 14 | 267 | 7 | 22095711 | ||
| Cytoband | 9p22 | 9.14e-11 | 25 | 267 | 7 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 8.77e-06 | 124 | 267 | 7 | chr9p21 | |
| GeneFamily | Interferons | 1.94e-08 | 32 | 175 | 7 | 598 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.64e-05 | 20 | 175 | 4 | 736 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | KIF1B PLEKHN1 PLEKHM1 PLEKHH1 ARHGEF7 PSD2 SH2B1 IRS2 ARHGEF2 | 1.83e-04 | 206 | 175 | 9 | 682 |
| GeneFamily | Ankyrin repeat domain containing | NFKBIA ANKRD28 ANKRD42 ANK2 ANKRD10 KRIT1 ANKRD60 ASB1 TANC1 | 5.97e-04 | 242 | 175 | 9 | 403 |
| GeneFamily | Fibronectin type III domain containing | 9.51e-04 | 160 | 175 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.87e-04 | 161 | 175 | 7 | 593 | |
| GeneFamily | Ring finger proteins | 1.47e-03 | 275 | 175 | 9 | 58 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 1.89e-03 | 7 | 175 | 2 | 135 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.30e-03 | 95 | 175 | 5 | 59 | |
| GeneFamily | Immunoglobulin like domain containing | 2.78e-03 | 193 | 175 | 7 | 594 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.21e-03 | 9 | 175 | 2 | 1280 | |
| GeneFamily | Proteases, serine | 3.24e-03 | 63 | 175 | 4 | 738 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.83e-03 | 66 | 175 | 4 | 722 | |
| Coexpression | NABA_MATRISOME | CD109 SPOCK2 SVEP1 IGSF10 SLIT2 FREM2 FBN2 SEMA5B FGF20 NTN5 FGF1 DMBT1 MMP16 USH2A MMP19 PAPPA2 SEMA7A LAMA2 MUC16 LAMB2 SEMA5A MUC5B VWCE ADAM22 IFNA2 IFNA4 IFNA8 LGALS2 IFNA10 IFNA16 IFNA17 IFNA21 TSKU HHIP LOX FGFBP3 TLL2 FRZB ADAMTS14 SEMA3E | 2.18e-13 | 1026 | 264 | 40 | M5889 |
| Coexpression | NABA_MATRISOME | CD109 SPOCK2 SVEP1 IGSF10 SLIT2 FREM2 FBN2 SEMA5B FGF20 NTN5 FGF1 DMBT1 MMP16 MMP19 PAPPA2 SEMA7A LAMA2 MUC16 LAMB2 SEMA5A MUC5B VWCE ADAM22 IFNA2 IFNA4 IFNA8 LGALS2 IFNA10 IFNA16 IFNA17 IFNA21 TSKU HHIP LOX FGFBP3 TLL2 FRZB ADAMTS14 SEMA3E | 5.70e-13 | 1008 | 264 | 39 | MM17056 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | CD109 FREM2 SEMA5B FGF20 FGF1 MMP16 MMP19 PAPPA2 SEMA7A MUC16 SEMA5A MUC5B ADAM22 IFNA2 IFNA4 IFNA8 LGALS2 IFNA10 IFNA16 IFNA17 IFNA21 HHIP LOX FGFBP3 TLL2 FRZB ADAMTS14 SEMA3E | 2.12e-09 | 738 | 264 | 28 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | CD109 FREM2 SEMA5B FGF20 FGF1 MMP16 MMP19 PAPPA2 SEMA7A MUC16 SEMA5A MUC5B ADAM22 IFNA2 IFNA4 IFNA8 LGALS2 IFNA10 IFNA16 IFNA17 IFNA21 HHIP LOX FGFBP3 TLL2 FRZB ADAMTS14 SEMA3E | 3.11e-09 | 751 | 264 | 28 | M5885 |
| Coexpression | LEE_AGING_NEOCORTEX_DN | UIMC1 IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 TRIM10 IFNA21 WDFY3 | 8.03e-09 | 80 | 264 | 10 | MM646 |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 1.25e-08 | 29 | 264 | 7 | MM586 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.13e-07 | 39 | 264 | 7 | M41095 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.41e-07 | 87 | 264 | 9 | MM652 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 2.44e-07 | 27 | 264 | 6 | M40935 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | ZXDC GAK PGAP3 ITFG2 ABHD3 SPOCK2 RAD54L2 CHKB DUS3L NFKBIA CACNA1I TTF2 TEPSIN HECTD4 NLRP1 GRN PITPNM1 ZNF827 PLA2G4B NISCH MDC1 TJAP1 | 5.56e-07 | 634 | 264 | 22 | M40866 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | ERCC6L FREM2 DMBT1 CR1 IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 ZNF827 | 1.62e-06 | 210 | 264 | 12 | MM751 |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 2.35e-06 | 85 | 264 | 8 | MM684 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 2.58e-06 | 182 | 264 | 11 | M8670 | |
| Coexpression | GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | GAK KIF1B SEMA5B NTN5 BRSK2 PCARE VWCE DCAF10 NISCH TLL2 EPHX3 | 3.02e-06 | 185 | 264 | 11 | M8680 |
| Coexpression | PEREZ_TP53_TARGETS | ZXDC GAK DIS3L2 KIF1B OBSCN MCF2 NEU3 DUS3L DACT1 HPN ZNF398 FGF1 ZFP90 AFF3 HECTD4 NLRP1 GRN CHST1 TNRC6C VWCE ELL3 RIMBP3 FGFBP3 ZNF746 FRZB GLIPR2 GPCPD1 DISP2 ALDH4A1 MXI1 | 4.75e-06 | 1201 | 264 | 30 | M4391 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SVEP1 IGSF10 SLIT2 FBN2 NTN5 DMBT1 USH2A LAMA2 LAMB2 VWCE TSKU | 5.26e-06 | 196 | 264 | 11 | M3008 |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 7.55e-06 | 131 | 264 | 9 | MM1127 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 1.65e-05 | 80 | 264 | 7 | MM1229 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ZXDC GAK PGAP3 ITFG2 ABHD3 SPOCK2 RAD54L2 CHKB DUS3L PLEKHM1 DENND6B CACNA1I TTF2 TEPSIN NLRP1 GRN CEP192 PITPNM1 ZNF827 PLA2G4B NISCH ZNF746 MDC1 TJAP1 | 1.72e-05 | 905 | 264 | 24 | M40865 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.19e-05 | 34 | 264 | 5 | M41094 | |
| Coexpression | NABA_CORE_MATRISOME | SPOCK2 SVEP1 IGSF10 SLIT2 FBN2 NTN5 DMBT1 USH2A LAMA2 LAMB2 VWCE TSKU | 2.51e-05 | 275 | 264 | 12 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.57e-05 | 191 | 264 | 10 | MM17059 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_UP | ETV4 RAD54L2 ANKRD28 WASHC4 CIR1 LGALS2 KMT2D GUCY2D ENTPD5 ZNF749 | 3.50e-05 | 198 | 264 | 10 | M5207 |
| Coexpression | NABA_CORE_MATRISOME | SPOCK2 SVEP1 IGSF10 SLIT2 FBN2 NTN5 DMBT1 LAMA2 LAMB2 VWCE TSKU | 1.01e-04 | 270 | 264 | 11 | MM17057 |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP | PTGER3 BBX GSPT2 NXF3 GRN TRIM10 PITPNM1 GPCPD1 ASB1 ARHGEF2 TRIM47 | 1.14e-04 | 274 | 264 | 11 | M2348 |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP | PTGER3 BBX GSPT2 NXF3 GRN TRIM10 PITPNM1 GPCPD1 ASB1 ARHGEF2 TRIM47 | 1.26e-04 | 277 | 264 | 11 | MM917 |
| Coexpression | NABA_SECRETED_FACTORS | FGF20 FGF1 IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 HHIP FGFBP3 FRZB | 1.79e-04 | 338 | 264 | 12 | MM17064 |
| Coexpression | NABA_SECRETED_FACTORS | FGF20 FGF1 IFNA2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 HHIP FGFBP3 FRZB | 2.04e-04 | 343 | 264 | 12 | M5883 |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 2.06e-04 | 200 | 264 | 9 | M3390 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 2.06e-04 | 200 | 264 | 9 | M5995 | |
| Coexpression | GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN | 2.06e-04 | 200 | 264 | 9 | M4845 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN | 2.06e-04 | 200 | 264 | 9 | M9835 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 2.06e-04 | 200 | 264 | 9 | M4016 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_LUNG_UP | 2.06e-04 | 200 | 264 | 9 | M4368 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.09e-04 | 158 | 264 | 8 | MM17063 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE | 2.24e-04 | 30 | 264 | 4 | M41011 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | SVEP1 IGSF10 TRIL SLIT2 DACT1 FBN2 PAPPA2 FAT3 LAMA2 ZNF521 MUC16 CRPPA HHIP FRZB GLIPR2 | 4.89e-06 | 310 | 252 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | ERCC6L SVEP1 IGSF10 TRIL SLIT2 DACT1 FBN2 PAPPA2 AMHR2 SEMA7A FAT3 AFF3 LAMA2 ZNF521 MUC16 CRPPA CPA1 SEMA5A CHST1 IGDCC4 HHIP SLF2 FRZB ENTPD5 GLIPR2 | 5.39e-06 | 768 | 252 | 25 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ABHD3 SVEP1 IGSF10 SLIT2 DACT1 KIF15 AMHR2 FAT3 AFF3 LAMA2 ZNF521 MUC16 CRPPA CPA1 SEMA5A CEP192 CHST1 IGDCC4 HHIP LOX MDC1 ENTPD5 GLIPR2 SORCS3 PRKCB | 9.35e-06 | 793 | 252 | 25 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | SVEP1 IGSF10 TRIL SLIT2 DACT1 MMP16 PAPPA2 FAT3 LAMA2 MUC16 CRPPA HHIP LOX GLIPR2 SORCS3 | 1.28e-05 | 336 | 252 | 15 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | ACADL FREM2 MAST4 PTPRG HPN DMBT1 WWC1 SYNE1 AFF3 LMO7DN HHIP PRKCZ USP54 | 9.25e-11 | 183 | 267 | 13 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | ACADL FREM2 MAST4 PTPRG HPN DMBT1 WWC1 AFF3 LMO7DN HHIP TANC1 PRKCZ USP54 | 1.29e-10 | 188 | 267 | 13 | eb6d79d733b53f64ca615bb777c64ed456866549 |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | ACADL FREM2 MAST4 PTPRG HPN DMBT1 WWC1 HHIP TANC1 PRKCZ USP54 | 1.79e-08 | 186 | 267 | 11 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | TMEM132C TRIL SLIT2 PTPRG FAT3 AFF3 ZNF521 CRPPA ADAM22 PRKCB TANC1 | 2.76e-08 | 194 | 267 | 11 | b1bb0f846d2865efdd9bc8842b16b9d069785882 |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.89e-07 | 69 | 267 | 7 | cdd42abdd072aa438830d837ee857529269a81e0 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.89e-07 | 69 | 267 | 7 | a157b1582401cebd222343d94086dbea876140c2 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | KCNB2 SVEP1 TMEM132C SLIT2 PTPRG MMP16 FAT3 LAMA2 ZNF521 SH3RF3 | 2.06e-07 | 187 | 267 | 10 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CMYA5 SVEP1 TMEM132C IGSF10 SLIT2 FAT3 LAMA2 HIF3A LMO4 PRKCB | 2.27e-07 | 189 | 267 | 10 | 203c80030df08ae112f9ae4043709f455d87ce89 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FREM2 MAST4 WWC1 LMO7DN HIF3A NHSL1 PRKCZ USP54 ARHGEF2 SEMA3E | 2.38e-07 | 190 | 267 | 10 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 TMEM132C IGSF10 SLIT2 ANK2 FAT3 SEMA5A IGDCC4 LOX SORCS3 | 2.50e-07 | 191 | 267 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.63e-07 | 192 | 267 | 10 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 TMEM132C IGSF10 SLIT2 ANK2 FAT3 SEMA5A IGDCC4 LOX SORCS3 | 2.63e-07 | 192 | 267 | 10 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 TMEM132C IGSF10 SLIT2 ANK2 FAT3 SEMA5A IGDCC4 LOX SORCS3 | 2.63e-07 | 192 | 267 | 10 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 TMEM132C IGSF10 SLIT2 ANK2 SYNE1 FAT3 SEMA5A IGDCC4 SORCS3 | 2.89e-07 | 194 | 267 | 10 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.03e-07 | 195 | 267 | 10 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TMEM132C TRIL SLIT2 PTPRG FAT3 AFF3 ZNF521 CRPPA ADAM22 PRKCB | 3.03e-07 | 195 | 267 | 10 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.18e-07 | 196 | 267 | 10 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-07 | 197 | 267 | 10 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SVEP1 TMEM132C IGSF10 SLIT2 MAST4 FAT3 AFF3 LAMA2 LMO4 PRKCB | 3.33e-07 | 197 | 267 | 10 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SVEP1 TMEM132C SLIT2 PTPRG MMP16 ANK2 SYNE1 LAMA2 ZNF521 SH3RF3 | 3.83e-07 | 200 | 267 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 158 | 267 | 9 | 66c011e9de002224f70725dfe8e7871c8d304492 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-07 | 163 | 267 | 9 | 66ecd544d7b52e61880b125bf39d1f406af6900a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-07 | 171 | 267 | 9 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.34e-06 | 178 | 267 | 9 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | KREMEN2 KCNB2 NFKBIA SEMA5A IGDCC4 SLCO5A1 TLL2 CEACAM16 SORCS3 | 1.34e-06 | 178 | 267 | 9 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-06 | 179 | 267 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.41e-06 | 179 | 267 | 9 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 181 | 267 | 9 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 1.85e-06 | 185 | 267 | 9 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 187 | 267 | 9 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-06 | 187 | 267 | 9 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-06 | 188 | 267 | 9 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-06 | 188 | 267 | 9 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-06 | 189 | 267 | 9 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-06 | 190 | 267 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.40e-06 | 191 | 267 | 9 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 192 | 267 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-06 | 192 | 267 | 9 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 192 | 267 | 9 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 192 | 267 | 9 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.51e-06 | 192 | 267 | 9 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-06 | 193 | 267 | 9 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.61e-06 | 193 | 267 | 9 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-06 | 193 | 267 | 9 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.61e-06 | 193 | 267 | 9 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-06 | 194 | 267 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-06 | 194 | 267 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-06 | 194 | 267 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-06 | 195 | 267 | 9 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.85e-06 | 195 | 267 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.85e-06 | 195 | 267 | 9 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 3.09e-06 | 197 | 267 | 9 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.09e-06 | 197 | 267 | 9 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.09e-06 | 197 | 267 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.22e-06 | 198 | 267 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.36e-06 | 199 | 267 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.36e-06 | 199 | 267 | 9 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.36e-06 | 199 | 267 | 9 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 199 | 267 | 9 | 7540973d36f78cd9f13210635ff0708d20c8b209 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 199 | 267 | 9 | 416ea20b49a48bf47ec3abfbe707e4d1254e2f88 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-06 | 200 | 267 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-06 | 200 | 267 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.49e-06 | 155 | 267 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-ILC3|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.94e-06 | 161 | 267 | 8 | 584e44e6048c2678eb72cd23a86f48f2466c5da4 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.94e-06 | 161 | 267 | 8 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.94e-06 | 161 | 267 | 8 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-06 | 166 | 267 | 8 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-06 | 166 | 267 | 8 | 3e3e9296e6919a38602e417a6606c046af3bd101 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-06 | 166 | 267 | 8 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.12e-06 | 168 | 267 | 8 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.12e-06 | 168 | 267 | 8 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.12e-06 | 168 | 267 | 8 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-06 | 169 | 267 | 8 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.48e-06 | 169 | 267 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.86e-06 | 170 | 267 | 8 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-06 | 172 | 267 | 8 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.99e-06 | 124 | 267 | 7 | 9f169fa17be1842a6bd83778ff30465a740edd5f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 174 | 267 | 8 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 174 | 267 | 8 | e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 174 | 267 | 8 | ad5b56f0ace6455c033834b931ec870cc0dc9290 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 174 | 267 | 8 | ce9bdd02dc8eb45ba9c1481619c0089b465e6442 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-B_cell-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 176 | 267 | 8 | 27c132e9852717cbc345af7a1fc390e9ea589416 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 176 | 267 | 8 | 259d1864fb0a6d2feddc90bc715e2bccbb373792 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 177 | 267 | 8 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-05 | 177 | 267 | 8 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 177 | 267 | 8 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 177 | 267 | 8 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.19e-05 | 177 | 267 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-05 | 177 | 267 | 8 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 178 | 267 | 8 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 178 | 267 | 8 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-05 | 178 | 267 | 8 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 179 | 267 | 8 | c1c0b7186a0eab8c76404b95f1cf8d64b1b45cb1 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 86 | 267 | 6 | 80aa7f0a7e43f8278b1af25ced8c069325ed3270 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.34e-05 | 180 | 267 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 181 | 267 | 8 | ce30724788d9b5c6dfa4f9f8d318c3d2565165ed | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-05 | 181 | 267 | 8 | 477c572c5c1efceee49732cc9e8b1dad68a7e6e5 | |
| Drug | Yfrkd | 5.93e-07 | 7 | 263 | 4 | CID000129984 | |
| Drug | 1hiv | 1.17e-06 | 8 | 263 | 4 | CID005479205 | |
| Drug | Chebi:36708 | 1.17e-06 | 8 | 263 | 4 | CID011966289 | |
| Drug | AC1Q5H8E | CENPB NEU3 FGF1 AMHR2 NCKIPSD GRN IFNA2 IFNA4 IFNA10 IFNA17 CORIN | 1.34e-06 | 149 | 263 | 11 | CID000114813 |
| Drug | AC1L1J6W | MYLK3 PRSS33 CUBN IFNA2 IFNA4 IFNA10 IGDCC4 IFNA17 PREB CD5 PRKCB PRKCZ | 1.85e-06 | 186 | 263 | 12 | CID000004894 |
| Drug | pipobroman | 3.46e-06 | 10 | 263 | 4 | CID000004842 | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | CHD3 MAST4 HPN FGF1 KIF13B SYNE1 LAMA2 LMO4 ERN2 TJAP1 ZNF749 IRS2 | 3.73e-06 | 199 | 263 | 12 | 7125_UP |
| Drug | FMAU | 3.86e-06 | 37 | 263 | 6 | CID000072327 | |
| Drug | flesinoxan | 5.39e-06 | 11 | 263 | 4 | CID000057347 | |
| Drug | barium iodide | 6.04e-06 | 4 | 263 | 3 | CID000083684 | |
| Drug | ridostin | 8.30e-06 | 116 | 263 | 9 | CID011979623 | |
| Drug | Sesquimustard | 9.56e-06 | 43 | 263 | 6 | CID000019092 | |
| Drug | R 842 | 1.15e-05 | 13 | 263 | 4 | CID000130714 | |
| Drug | inosiplex | 1.30e-05 | 27 | 263 | 5 | CID000037510 | |
| Drug | VX-497 | 1.30e-05 | 27 | 263 | 5 | CID000153241 | |
| Drug | B132 | 1.50e-05 | 5 | 263 | 3 | CID002734031 | |
| Drug | Lanicemine | 1.59e-05 | 14 | 263 | 4 | CID003038485 | |
| Drug | gunacin | 1.59e-05 | 14 | 263 | 4 | CID000198547 | |
| Drug | NM 108 | 1.87e-05 | 29 | 263 | 5 | CID000500901 | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A | SPOCK2 ATP10B PTGER3 FGF1 DMBT1 MMP16 PAPPA2 LECT2 SLCO1A2 GUCY2D SEMA3E | 2.15e-05 | 199 | 263 | 11 | 4330_UP |
| Drug | pppA2'-5'A2'-5'A | 2.15e-05 | 15 | 263 | 4 | CID000125229 | |
| Drug | penciclovir | 2.23e-05 | 30 | 263 | 5 | CID000004725 | |
| Drug | HCV-371 | 2.97e-05 | 6 | 263 | 3 | CID003013096 | |
| Drug | YNK01 | 3.68e-05 | 17 | 263 | 4 | CID000084071 | |
| Drug | p203 | 4.69e-05 | 18 | 263 | 4 | CID000019228 | |
| Drug | podophyllin | 4.69e-05 | 18 | 263 | 4 | CID011979494 | |
| Drug | Nyco | 4.69e-05 | 18 | 263 | 4 | CID000071618 | |
| Drug | lobucavir | 4.84e-05 | 35 | 263 | 5 | CID000060786 | |
| Drug | SAR 020106 | 5.15e-05 | 7 | 263 | 3 | ctd:C547874 | |
| Drug | A809128 | 5.57e-05 | 36 | 263 | 5 | CID003392279 | |
| Drug | fotemustine | 7.28e-05 | 38 | 263 | 5 | CID000104799 | |
| Drug | Ciluprevir [USAN] | 7.29e-05 | 20 | 263 | 4 | CID006450803 | |
| Drug | val-mCyd | 7.29e-05 | 20 | 263 | 4 | CID006918726 | |
| Drug | AC1LAD6M | 8.18e-05 | 8 | 263 | 3 | CID000511663 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 8.18e-05 | 8 | 263 | 3 | CID010011375 | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 8.74e-05 | 193 | 263 | 10 | 2829_UP | |
| Drug | L DO | 8.92e-05 | 21 | 263 | 4 | CID000097725 | |
| Drug | 2-propylpentanoic acid; Up 200; 2000uM; MCF7; HG-U133A | 9.12e-05 | 194 | 263 | 10 | 346_UP | |
| Drug | oligoadenylate | 9.14e-05 | 157 | 263 | 9 | CID000107918 | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | PGAP3 ITFG2 RAD54L2 CACNA1I SH2B1 TSKU KMT2D TJAP1 PRKCB IRS2 | 9.52e-05 | 195 | 263 | 10 | 2770_UP |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | RAD54L2 FCHO1 SLIT2 MAST4 ARHGEF7 TMEM132A CACNA1I MMP16 MMP19 KIF13B | 9.52e-05 | 195 | 263 | 10 | 5228_DN |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; HL60; HT_HG-U133A | 9.93e-05 | 196 | 263 | 10 | 2344_DN | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | NEU3 FGF1 MMP16 SYNE1 DUSP7 LOX SLCO1A2 ENTPD5 ARHGEF2 MAPK8IP2 | 9.93e-05 | 196 | 263 | 10 | 2098_UP |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | UMOD CACNA1I MMP16 MMP19 KLK15 DUSP7 SEMA5A CHST1 ERN2 ADAM22 | 1.04e-04 | 197 | 263 | 10 | 3877_UP |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | PGAP3 ITFG2 SPOCK2 PTGER3 FGF1 SEMA7A ERN2 ADAM22 SLCO5A1 LOX | 1.04e-04 | 197 | 263 | 10 | 4433_UP |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A | USP34 PGAP3 SPOCK2 FCHO1 MAST4 DMBT1 WWC1 PAPPA2 LETM1 ALDH4A1 | 1.04e-04 | 197 | 263 | 10 | 6570_DN |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; HL60; HT_HG-U133A | 1.04e-04 | 197 | 263 | 10 | 2992_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; HL60; HT_HG-U133A | MCF2 DACT1 FGF20 YWHAH-AS1 LAMB2 NLRP1 LOX TRIM62 ZNF749 SPIDR | 1.08e-04 | 198 | 263 | 10 | 2552_UP |
| Drug | Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | SIGLEC5 SPOCK2 CACNA1I ANK2 HIF3A ADAM22 MST1R CD5 GUCY2D TJAP1 | 1.08e-04 | 198 | 263 | 10 | 3976_UP |
| Drug | Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; MCF7; HT_HG-U133A | MARS1 SVEP1 SLIT2 KLK15 ERN2 ADAM22 SLCO1A2 ZNF749 SPIDR ARHGEF2 | 1.08e-04 | 198 | 263 | 10 | 3533_UP |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; HL60; HG-U133A | 1.08e-04 | 198 | 263 | 10 | 1733_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A | ITFG2 SPOCK2 ZNF318 RUSC2 DLEC1 HIF3A ADAM22 LOX SORCS3 SPIDR | 1.08e-04 | 198 | 263 | 10 | 6496_UP |
| Drug | formosanin C | 1.08e-04 | 22 | 263 | 4 | CID000073597 | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | SPOCK2 CHD3 RAD54L2 RGP1 TRAFD1 MMP19 PAPPA2 ANK2 BEND5 LAMA2 | 1.13e-04 | 199 | 263 | 10 | 3140_DN |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; HL60; HG-U133A | ABHD3 NEU3 SPOCK2 FCHO1 YWHAH-AS1 PAPPA2 CD5 TJAP1 INTS9 SPIDR | 1.13e-04 | 199 | 263 | 10 | 2023_UP |
| Drug | rapamycin; Down 200; 0.1uM; ssMCF7; HG-U133A | KREMEN2 ABHD3 ZNF318 RGP1 SLIT2 TRAFD1 DLEC1 L1CAM ADAM22 ECE2 | 1.13e-04 | 199 | 263 | 10 | 402_DN |
| Drug | SB 202190; Up 200; 1uM; PC3; HT_HG-U133A | PGAP3 ITFG2 PEX7 PAPPA2 BEND5 SEMA5A KRIT1 TRIM62 TJAP1 IRS2 | 1.13e-04 | 199 | 263 | 10 | 7058_UP |
| Drug | AC1O51IP | 1.14e-04 | 66 | 263 | 6 | CID006450363 | |
| Drug | 1 ind | 1.19e-04 | 42 | 263 | 5 | CID003037877 | |
| Drug | Telaprevir | 1.22e-04 | 9 | 263 | 3 | CID003010818 | |
| Drug | boceprevir | 1.22e-04 | 9 | 263 | 3 | CID010324367 | |
| Drug | Hiltonol | 1.30e-04 | 23 | 263 | 4 | CID000431963 | |
| Drug | 3,5-dinitrosalicylic acid hydrazide | 1.33e-04 | 2 | 263 | 2 | CID003663247 | |
| Drug | biurea | 1.33e-04 | 2 | 263 | 2 | CID000008039 | |
| Drug | NSC 312887 | 1.33e-04 | 43 | 263 | 5 | CID000003368 | |
| Drug | indole alkaloid | KLK15 NLRP1 IFNA2 IFNA4 IFNA10 IGDCC4 IFNA17 PREB CD5 PRKCB PRKCZ | 1.35e-04 | 244 | 263 | 11 | CID000005978 |
| Drug | imiquimod | 1.53e-04 | 132 | 263 | 8 | CID000057469 | |
| Drug | AC1L1ZCT | 1.54e-04 | 24 | 263 | 4 | CID000038235 | |
| Drug | cycloferon | 1.54e-04 | 24 | 263 | 4 | CID000038072 | |
| Drug | AC1L9NBB | 1.60e-04 | 169 | 263 | 9 | CID000449615 | |
| Disease | spontaneous preterm birth | MYT1L SVEP1 SLIT2 PTPRG DLEC1 B3GLCT C10orf90 NHSL1 INTS9 ADAMTS14 | 1.68e-08 | 101 | 252 | 10 | EFO_0006917 |
| Disease | cortical surface area measurement | USP34 KIF1B RGP1 PLEKHM1 SVEP1 SLIT2 DACT1 FBN2 MAST4 PMPCA IGSF9 RPS6KL1 WWC1 AMHR2 ZAN FAT3 BRSK2 LAMA2 CRPPA SEMA5A NHSL1 HHIP FRZB MDC1 PRKCZ SH3RF3 | 9.55e-05 | 1345 | 252 | 26 | EFO_0010736 |
| Disease | Colorectal Carcinoma | CD109 OBSCN KCNB2 GGH DACT1 FBN2 MYLK3 ANK2 SYNE1 CUBN IFNA2 MSH6 HHIP SLCO1A2 PRKCB PRKCZ TRAF3IP3 | 1.26e-04 | 702 | 252 | 17 | C0009402 |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 2.17e-04 | 3 | 252 | 2 | EFO_0803063 | |
| Disease | nitric oxide exhalation measurement | 3.05e-04 | 38 | 252 | 4 | EFO_0005536 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.83e-04 | 17 | 252 | 3 | DOID:9884 (is_implicated_in) | |
| Disease | hippocampal CA4 volume | 4.10e-04 | 41 | 252 | 4 | EFO_0009396 | |
| Disease | primary progressive multiple sclerosis (is_implicated_in) | 7.14e-04 | 5 | 252 | 2 | DOID:0050784 (is_implicated_in) | |
| Disease | Nasopharyngeal carcinoma | 8.41e-04 | 22 | 252 | 3 | C2931822 | |
| Disease | Malignant neoplasm of breast | CD109 OBSCN ETV4 ZNF318 ADAR SEMA5B NFKBIA DLEC1 KLK15 ANK2 SYNE1 LAMA2 CUBN MAMDC4 IFNA2 LGALS2 MSH6 KMT2D NISCH USP54 | 9.83e-04 | 1074 | 252 | 20 | C0006142 |
| Disease | Congenital muscular dystrophy (disorder) | 1.07e-03 | 6 | 252 | 2 | C0699743 | |
| Disease | retinal disease (implicated_via_orthology) | 1.07e-03 | 6 | 252 | 2 | DOID:5679 (implicated_via_orthology) | |
| Disease | PR interval | OBSCN CHKB FREM2 FBN2 NFKBIA ALPK3 DLEC1 TBX20 KIF13B LAMB2 ADAM22 TJAP1 | 1.22e-03 | 495 | 252 | 12 | EFO_0004462 |
| Disease | Neurodevelopmental Disorders | 1.23e-03 | 93 | 252 | 5 | C1535926 | |
| Disease | idiopathic pulmonary fibrosis | 1.44e-03 | 57 | 252 | 4 | EFO_0000768 | |
| Disease | non-alcoholic fatty liver disease severity measurement | 1.72e-03 | 28 | 252 | 3 | EFO_0008421 | |
| Disease | blood cobalt measurement | 1.78e-03 | 101 | 252 | 5 | EFO_0007577 | |
| Disease | sialic acid-binding Ig-like lectin 6 measurement | 1.97e-03 | 8 | 252 | 2 | EFO_0008285 | |
| Disease | cardiovascular measurement, left ventricular function | 1.97e-03 | 8 | 252 | 2 | EFO_0004295, EFO_0004298 | |
| Disease | arylsulfatase A measurement | 1.97e-03 | 8 | 252 | 2 | EFO_0020163 | |
| Disease | waist-hip ratio | DIS3L2 ZNF318 KCNB2 BBX MAST4 PTPRG FGF1 ANKRD28 DLEC1 MMP16 PAPPA2 IQCH AFF3 HECTD4 CPA1 CEP192 SH2B1 HHIP NISCH GPCPD1 ASB1 | 2.06e-03 | 1226 | 252 | 21 | EFO_0004343 |
| Disease | neuroimaging measurement | KMT2B KIF1B RGP1 SLIT2 DACT1 FBN2 MAST4 IGSF9 WWC1 FAT3 AFF3 BRSK2 LAMA2 ZNF521 NHSL1 HHIP PRKCZ TRIM47 SH3RF3 | 2.22e-03 | 1069 | 252 | 19 | EFO_0004346 |
| Disease | Disorder of eye | 2.40e-03 | 212 | 252 | 7 | C0015397 | |
| Disease | Calcium channel blocker use measurement | 2.46e-03 | 213 | 252 | 7 | EFO_0009930 | |
| Disease | Colorectal Neoplasms | 2.75e-03 | 277 | 252 | 8 | C0009404 | |
| Disease | brain measurement, neuroimaging measurement | RGP1 SLIT2 DACT1 FBN2 MAST4 IGSF9 FAT3 BRSK2 NHSL1 HHIP PRKCZ SH3RF3 | 2.91e-03 | 550 | 252 | 12 | EFO_0004346, EFO_0004464 |
| Disease | COVID-19 symptoms measurement | 3.29e-03 | 35 | 252 | 3 | EFO_0600019 | |
| Disease | blood nickel measurement | 3.75e-03 | 120 | 252 | 5 | EFO_0007583 | |
| Disease | response to statin, myopathy | 3.80e-03 | 11 | 252 | 2 | EFO_0004145, GO_0036273 | |
| Disease | nucleus accumbens volume change measurement | 3.80e-03 | 11 | 252 | 2 | EFO_0021493 | |
| Disease | forced expiratory volume, body mass index | 3.80e-03 | 11 | 252 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | dentate gyrus volume measurement | 4.48e-03 | 39 | 252 | 3 | EFO_0010083 | |
| Disease | schizophrenia (is_implicated_in) | 4.52e-03 | 78 | 252 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Behavior Disorders | 4.53e-03 | 12 | 252 | 2 | C0004930 | |
| Disease | Mental disorders | 4.53e-03 | 12 | 252 | 2 | C0004936 | |
| Disease | Mental Disorders, Severe | 4.53e-03 | 12 | 252 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 4.53e-03 | 12 | 252 | 2 | C0376338 | |
| Disease | multiple system atrophy | 4.82e-03 | 40 | 252 | 3 | EFO_1001050 | |
| Disease | tea consumption measurement | 5.10e-03 | 129 | 252 | 5 | EFO_0010091 | |
| Disease | Hodgkin lymphoma, lymphocyte depletion | 5.33e-03 | 13 | 252 | 2 | C0152267 | |
| Disease | Mixed Cellularity Hodgkin Lymphoma | 5.33e-03 | 13 | 252 | 2 | C0152266 | |
| Disease | Lymphocyte Rich Classical Hodgkin Lymphoma | 5.33e-03 | 13 | 252 | 2 | C1266194 | |
| Disease | Adult Hodgkin Lymphoma | 5.33e-03 | 13 | 252 | 2 | C0220597 | |
| Disease | Nodular Lymphocyte Predominant Hodgkin Lymphoma | 5.33e-03 | 13 | 252 | 2 | C1334968 | |
| Disease | Hamman-Rich syndrome | 6.18e-03 | 14 | 252 | 2 | C0085786 | |
| Disease | trimethylamine-N-oxide measurement | 6.18e-03 | 14 | 252 | 2 | EFO_0010541 | |
| Disease | age at last pregnancy measurement | 6.18e-03 | 14 | 252 | 2 | EFO_0009440 | |
| Disease | uric acid measurement | USP34 ZNF318 PLEKHH1 TRAFD1 UMOD ANKRD28 FAT3 HECTD4 CUBN ZNF827 GUCY2D TANC1 | 6.55e-03 | 610 | 252 | 12 | EFO_0004761 |
| Disease | cytokine measurement | 6.61e-03 | 461 | 252 | 10 | EFO_0004873 | |
| Disease | pain | 6.94e-03 | 196 | 252 | 6 | EFO_0003843 | |
| Disease | relapsing-remitting multiple sclerosis (is_marker_for) | 7.09e-03 | 15 | 252 | 2 | DOID:2378 (is_marker_for) | |
| Disease | cancer biomarker measurement | 7.09e-03 | 15 | 252 | 2 | EFO_0005127 | |
| Disease | Hepatitis C | 7.09e-03 | 15 | 252 | 2 | C0019196 | |
| Disease | Lymphoma, Follicular, Grade 2 | 7.09e-03 | 15 | 252 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 7.09e-03 | 15 | 252 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 7.09e-03 | 15 | 252 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 7.09e-03 | 15 | 252 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 7.09e-03 | 15 | 252 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 7.09e-03 | 15 | 252 | 2 | C0079758 | |
| Disease | tonsillectomy risk measurement | 7.24e-03 | 260 | 252 | 7 | EFO_0007924 | |
| Disease | gliosarcoma | 8.06e-03 | 16 | 252 | 2 | C0206726 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 8.06e-03 | 16 | 252 | 2 | C1257877 | |
| Disease | calcium measurement | CD109 ZNF318 GGH FBN2 BBX SEMA5B HPN DMBT1 SIGLEC12 CRPPA GPCPD1 IRS2 | 8.16e-03 | 628 | 252 | 12 | EFO_0004838 |
| Disease | emphysema imaging measurement | 8.50e-03 | 146 | 252 | 5 | EFO_0007626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSCGGRHQSPIDILD | 76 | P23470 | |
| CHPDLAGSELQRGTL | 66 | A6NGE7 | |
| NGLSLGHSTCPEEVF | 146 | Q7L4P6 | |
| TERTSAGDGANCHRP | 591 | P51826 | |
| NPLTCGRHIATDFET | 261 | Q6UXC1 | |
| GGRSCTDSELLLHPE | 6 | Q9BVC5 | |
| RFLRSGPNSLHCLGS | 91 | Q9HB65 | |
| NGCVINGHLDFPSTT | 276 | Q9NXR5 | |
| TVDLGIPNTDRGHCG | 311 | Q6Y288 | |
| EHALGTPEVSSGTCR | 216 | Q8WY36 | |
| QLPAARCSHSGGEER | 21 | P28330 | |
| RCSHSGGEERLETPS | 26 | P28330 | |
| CFSGAREGHLPSLLA | 341 | Q9NS82 | |
| SHTAGSLCIGVDPNR | 241 | P15085 | |
| CPGSTRNFVIHRLGD | 306 | Q92974 | |
| HTGREVGFPNCSLLV | 376 | Q2WEN9 | |
| PLRIAATAGHGSCVD | 81 | Q9Y576 | |
| TTLSRHLGGPCQVDA | 51 | P28799 | |
| CAARSEGLLPSFHTI | 251 | Q9BYG8 | |
| CGEEPSHAFQGLSLL | 191 | O00155 | |
| AGHRTPGEVLECQTT | 746 | Q96L96 | |
| IRGNPDSFVALSTCH | 141 | Q9P0K1 | |
| CGSFLKHLPETEAGR | 206 | P06127 | |
| DSRGRTPIHLSAACG | 716 | O15084 | |
| EHGASCLSRSPLGRT | 241 | Q9BZ19 | |
| GGESFSRFLQDHCPV | 61 | Q8WU67 | |
| GPLFGDTVTSSEHLC | 266 | P30038 | |
| GLGSDSVCARPSSHR | 136 | Q14155 | |
| TCRFAGAHLRPEGQN | 176 | Q96G46 | |
| GTEPRLGGHCLNSSL | 1221 | Q9Y4B4 | |
| NLGCQSASHVGPFID | 231 | Q9UBZ4 | |
| IKHCRLFSEGGNFSP | 1041 | Q9P1Z9 | |
| GGLSNLLFRCSLPDH | 76 | Q9Y259 | |
| GSAFICPEFRHLLNG | 276 | P20711 | |
| DFLRSLEHAGPQLTC | 461 | Q8NEG7 | |
| LAFTLDHETGLPQGC | 556 | Q8IYB7 | |
| GGSELEPSGHQLFCL | 96 | Q2NKX9 | |
| SSLPGLGDRAALCSH | 106 | A7MBM2 | |
| PNGICHLETASLDGE | 196 | O94823 | |
| HPDQTRTGFGCESLL | 256 | O94823 | |
| RTNANSLGHCEGDRP | 996 | Q8WXS8 | |
| SLGHCEGDRPDTVQV | 1001 | Q8WXS8 | |
| PELCFSQVIREGGHA | 201 | Q16671 | |
| LTAQDDRGCTPLHLA | 91 | Q8N9B4 | |
| ICHSFTSQGGGREPL | 191 | P43268 | |
| ENGTARFECHIEGLP | 156 | Q8TDY8 | |
| THGTFRIVTENIPCG | 931 | Q9HC84 | |
| PRGTNCTFAHSQEEL | 426 | Q9HBD1 | |
| GQQHLRGRPCSDDVT | 501 | Q96DM1 | |
| EELVNRGHCSRPGAS | 141 | A6NNM3 | |
| LQARVASGPCSDLHT | 496 | A6NNM3 | |
| EELVNRGHCSRPGAS | 141 | A6NJZ7 | |
| LQARVASGPCSDLHT | 496 | A6NJZ7 | |
| GHLDCSLSTLEVPRF | 861 | Q86VS3 | |
| CVVFTGHPSLRFGDV | 391 | Q9NV88 | |
| PCLSGQRGADHTASA | 16 | A4D126 | |
| TRDGLTPLHCAARSG | 296 | Q01484 | |
| SLASGCHQALREPGR | 126 | Q9Y442 | |
| RGHSPSCLARVTGEL | 641 | O14526 | |
| GQQSPRATLCGTEAH | 311 | Q9H4D5 | |
| HTGVDSLCNFSPLAR | 14386 | Q8WXI7 | |
| CTPSTEAQRGLHLDF | 256 | O60320 | |
| GSSGRFLSPEQHACS | 46 | Q8TAT2 | |
| SLGCDLPQTHSLGNR | 21 | P01566 | |
| EGTDGHTFRSACLPR | 261 | O75356 | |
| CNVEPVGRLHIFSGA | 26 | Q14676 | |
| IIANVHPGSRCFGET | 336 | Q9NS87 | |
| HPGSRCFGETLSTLN | 341 | Q9NS87 | |
| QTGAPCLSFDIVRDH | 61 | Q9BQ67 | |
| DAVLTLTRHCPSEGS | 306 | Q02846 | |
| GFRPSGCITTIHEDE | 491 | Q8IX03 | |
| INGSLFCEHDRPTAL | 131 | P61968 | |
| EGSVGNLDNLSCFHP | 411 | Q96S65 | |
| LRFQMSLPGHEDCGT | 491 | Q86UW9 | |
| GTLCPTGEQRIHARE | 41 | Q5VT28 | |
| GSSPIFHGCVNERLA | 891 | O60333 | |
| GHALSPRLECSGTFS | 66 | F2Z398 | |
| RCSFSLHSGIPGTEG | 671 | Q76MJ5 | |
| NGEHRCSRDSLPSSF | 521 | Q5HYC2 | |
| RGHLECTDQPGVSIT | 1466 | Q5SZK8 | |
| SLGCDLPQTHSLGNR | 21 | P01568 | |
| LSLSGGGPEFQRCSH | 736 | Q13387 | |
| GDPAHLSCASTLGLR | 31 | O95202 | |
| QVGDSLLETSCGSPH | 166 | Q8IWQ3 | |
| NSRDFLRHFGCPVGS | 786 | P0DPD6 | |
| SLGCDLPETHSLDNR | 21 | P01562 | |
| LCNSSDGFGNPRHSV | 626 | Q5SYE7 | |
| DPSNLCHSGRTFDVQ | 511 | Q8IYD1 | |
| ERGRFNCGASLISPH | 41 | Q9H2R5 | |
| CSNTFDGPGRVLAHA | 166 | Q99542 | |
| FGQVHRCTEKSTGLP | 526 | Q32MK0 | |
| EHIDPSGRLCTFFGL | 121 | P43115 | |
| DPTVGKSLCTFRGHE | 141 | O00628 | |
| IHELPAGCTQGSERR | 121 | Q9C000 | |
| PEVLGESDHGNCITS | 401 | Q5QP82 | |
| PSSEHVAEIVGRQGC | 186 | Q86XN8 | |
| RPHQGVDILCSAGST | 51 | O14960 | |
| GRCDSHDDPALGLVS | 421 | P55268 | |
| DSRGIDTPQCHRFTG | 1146 | P55268 | |
| GSLHSPGLSECFQVN | 26 | Q8NCW0 | |
| SHLYGPGETARLDCQ | 341 | P32004 | |
| PLHRSACEGDSELLS | 291 | O00522 | |
| LSRDSLLSGCHPGFG | 86 | Q9UHN1 | |
| NNFSPTCHLDRSLGL | 816 | P24043 | |
| DFRGNTPLHLACEQG | 141 | P25963 | |
| FLASQHRVLPEGATC | 2526 | Q9UMN6 | |
| GQEQREDHLCFSPGS | 66 | P05162 | |
| NVPSLCGTDHTERRG | 146 | P05771 | |
| RHFEASCGQLSPARG | 346 | Q96N21 | |
| QEASVGTGTFRFHCP | 181 | P0C869 | |
| PLLDSRTCDGLYHVG | 186 | Q8NF86 | |
| ADACQALVGPTAHSR | 2961 | Q9Y4D8 | |
| PLCEISRGTHNFSEE | 201 | P51617 | |
| GTLLERVDTCHTPFG | 756 | P52701 | |
| SGIVNVSERHSCPLG | 16 | Q9Y2T5 | |
| SHLDGTTPVCEDIGR | 401 | P31930 | |
| GSLFPHAICLGDVDN | 16 | Q969R8 | |
| GFFCVDEGRLPHTQR | 116 | P05981 | |
| RDGLRFQQGPTCHLA | 2111 | Q5VST9 | |
| SPGDLRAFCSHRSNT | 506 | Q9Y4H2 | |
| LDHADVVNCTSIGPG | 1401 | Q9BXP8 | |
| GRFCGSSLPHELLSS | 546 | O60494 | |
| SCSADFLHLGDLPGE | 1006 | O14976 | |
| AQCPTLHFLEGGEDS | 496 | P07199 | |
| HVDLNVCTSFSGPGR | 1296 | Q6YHK3 | |
| SSPLGELFDHGCDSL | 146 | Q9Y6K0 | |
| SGESLSLHCVSDGIP | 2446 | Q6WRI0 | |
| SRFVPSSLCGESDIH | 646 | Q9NPB8 | |
| PSNCLGIRGFADAHS | 191 | Q6TDP4 | |
| VNLDASGSQCGLHSP | 676 | Q92953 | |
| STFPQSAAICGLRHE | 81 | Q9BX69 | |
| QEHARCSAIGTGESP | 461 | Q9NYF0 | |
| RSLPQRGVDCLSSHF | 116 | P55265 | |
| EGGEAHSCRRSQPET | 21 | Q96Q40 | |
| DLRGAASLHCTPQGD | 1231 | P17927 | |
| CGAASLELSRPHGDT | 16 | Q92820 | |
| ILKHSPESSRGQCGE | 51 | Q9H4G4 | |
| GEIVRLTTPGFSHSC | 536 | Q86TI2 | |
| RHLCEPGADGSETFA | 1461 | Q12873 | |
| CQHEDGRRPSGLGST | 556 | Q9P0X4 | |
| CRQHSPEGEGLRSFS | 3841 | Q8N3K9 | |
| CDGSHFFQRTGLSPL | 71 | P0C7P0 | |
| HPDLKTDGFGIDTCR | 131 | P04632 | |
| LAPRGHFVTCVQASD | 2406 | Q8TDW7 | |
| GITDPCESGNFRVHT | 286 | Q12905 | |
| SFEQCSGELSLPVHL | 386 | Q9NSG2 | |
| FERTLGLSSPCDNHA | 381 | Q16829 | |
| DNLPRGSRAHITLGC | 321 | P09543 | |
| IDGDDSHGLLPCRSF | 201 | Q9Y5Q5 | |
| QVGDSLLETSCGSPH | 181 | Q8TDC3 | |
| CLSDPSLGEHGFLNL | 66 | Q9H6B9 | |
| SVGCDLPQTHSLGSR | 21 | P01563 | |
| RRFACTAHTQGLSPG | 336 | P28300 | |
| LSSLENCAHAPERVG | 561 | P10911 | |
| APGTLQDGLCHSLDR | 1641 | O15021 | |
| PGETSESCLELENHG | 2286 | Q8TEP8 | |
| AAFRCSPISGLLESH | 2331 | Q8TEP8 | |
| ITHGTNPITFEDRLC | 21 | Q3LI81 | |
| DGGTLSRQHNCGTPL | 556 | Q9NV70 | |
| SLGCDLPQTHSLGNR | 21 | P32881 | |
| TLHAGDREDPSGCFT | 981 | Q5M9N0 | |
| DAQGHCLPDGRTENT | 856 | Q49AJ0 | |
| DVLRGPNVCGSRFHS | 81 | P35556 | |
| NRGGIHRPLSFTCSL | 6 | A0A1B0GTK4 | |
| PSSGQLHSLGECRVD | 916 | Q9Y238 | |
| SGPIALDDVRCSGHE | 161 | Q9UGM3 | |
| SLGCDLPQTHSLGNR | 21 | P01571 | |
| ILRGNGSEAHRVPCS | 166 | P11049 | |
| LCGSAPNSRAGFVHS | 981 | Q2NKX8 | |
| CDSFGIGVSVEPHLS | 456 | A6NGG8 | |
| VSEDGPQAVSSGHRC | 701 | A6NNC1 | |
| CSGGALNHFRSRQPI | 41 | Q96FM1 | |
| CRTGFHLQILPDGSV | 71 | Q9NP95 | |
| HRSSIPGCGVTFEIV | 1291 | Q9NQT8 | |
| RCESVGPAHSDGRFE | 581 | Q9Y4G2 | |
| EFPGSLSAASHLNCR | 931 | Q8N2Y8 | |
| DTGLLCIHASADPRQ | 386 | Q10713 | |
| INSAGLHATTCDGEP | 3006 | O75445 | |
| ISPHDLSLESCRVGG | 101 | Q9NRF2 | |
| SSGLCLGNPRADSIH | 206 | Q9UN30 | |
| SPTRFTHCEQVLGEG | 461 | Q96LD4 | |
| DGSTLRTLCLQHGPL | 1526 | Q9HCJ0 | |
| SVCPLEGSREHAFQI | 146 | Q494U1 | |
| GHFGFECLPNQLVSR | 31 | Q6ZU15 | |
| VCEADQSHGGPRSLS | 266 | O14545 | |
| EGCTSQVPRGTLAEH | 116 | Q2KHN1 | |
| GRCHTLLSPVTEESG | 5851 | Q8NF91 | |
| LSRGTAHPGEVTATC | 651 | Q24JP5 | |
| QDEHTTIIDRGPGAC | 991 | Q8N3T6 | |
| TIIDRGPGACEESNH | 996 | Q8N3T6 | |
| TALANTCGELEPTHR | 246 | Q7Z3H4 | |
| ACALSPGNHLGARET | 46 | Q8WTR8 | |
| SQTVFLPHRGERGQC | 76 | Q92546 | |
| EELVNRGHCSRPGAS | 141 | Q9UFD9 | |
| LQARVASGPCSDLHT | 496 | Q9UFD9 | |
| ALGRDHSGSVVSEPC | 731 | Q9UPU3 | |
| SLGCDLPQTHSLGNR | 21 | P05015 | |
| HSICSQRKGFPTEGE | 301 | Q6IN84 | |
| EAQRGEVTGPRAHSC | 61 | Q8N2H9 | |
| GRGPQSESIVCVHFL | 326 | Q9Y2N7 | |
| CSNGGHFLRILPDGT | 31 | P05230 | |
| PSTSAGLGDCNHRVD | 86 | Q9H2Y9 | |
| SAEEGGFTCRAQHPL | 306 | O15389 | |
| GGLATCSDVRHPASL | 1646 | Q9C0D5 | |
| CHLPGENASSGTELI | 626 | P46721 | |
| LGLCTSIHPEGYQDR | 921 | Q8IX21 | |
| GLLTGDVQLHPEASC | 381 | Q15477 | |
| SLGCDLPQTHSLGNR | 21 | P05014 | |
| NLPECGITHEQRAGS | 431 | Q9UBF8 | |
| NRGYSLEGPSEAHCT | 3326 | Q4LDE5 | |
| GTLESGHPRNLTCSV | 281 | Q96PQ1 | |
| TCRGHIPGFLQTTAD | 151 | Q96QV1 | |
| GVCRAGFERQHSLPS | 136 | Q9NZQ3 | |
| ACPTRNLTVDGHFGV | 531 | Q13591 | |
| FHTCPGLAEAGLAER | 31 | O43916 | |
| HVNTDRECPLFGLSG | 136 | Q86X95 | |
| PLGELFDHGCDSLST | 126 | Q8WUD6 | |
| ETPSLRRVHLGTGAC | 346 | Q96M02 | |
| TTEFCPHGPRRASQD | 31 | Q8N4M7 | |
| PGSVLHASVLCEDSG | 71 | Q6P3X8 | |
| EILSHLQGDCTSPGR | 406 | Q9UQ49 | |
| CHSLGTARGSPEEEL | 291 | Q5JTD0 | |
| SFCDGLTHDPLRQKA | 1091 | O00562 | |
| DGSNFLPLRTKSCGH | 286 | Q9HCU5 | |
| QLSATGCRDPSTEAH | 216 | Q9NYW3 | |
| PSGICRDLSDHLSSQ | 131 | Q9Y228 | |
| HLSENPFTCREGGKV | 186 | P52740 | |
| TCHRGAVTGLTATPD | 781 | Q96KV7 | |
| PVEGCGKSFTRAEHL | 391 | Q2QGD7 | |
| QSHTGESPFKLRECG | 716 | O43361 | |
| HLDSISPRGSCLESG | 241 | Q6ZSR9 | |
| LGPGNHDQEFISCLA | 2131 | Q8IZQ1 | |
| DGPCGTVLTRNETHA | 386 | P07911 | |
| CGVPDQTRGSSKFHI | 101 | P51512 | |
| NTSSFRQHGPLICDG | 526 | Q7RTY8 | |
| QFEGLLGTHCSPDLL | 71 | Q92765 | |
| SGHTDPAGTRACLLV | 506 | Q14159 | |
| SEGLNSSLCSPGHER | 36 | Q9BQI7 | |
| SLSIHGRAGSCPIES | 766 | Q8TEJ3 | |
| HCDLSGSRFGSPVLG | 536 | Q96K83 | |
| PQCGIDFNGHSALIR | 486 | Q8TD17 | |
| DHCAGLVTLPEAGSR | 676 | Q7L0X0 | |
| TRSCTQPRGAFADGH | 956 | Q9Y2I1 | |
| AGRSLHGDTEAPVNC | 766 | Q96DN2 | |
| HGRFCGSETPEVITS | 691 | Q9Y6L7 | |
| GVCFPLHSEDTESIG | 561 | Q9HBX9 | |
| RSEGLLACGTNARHP | 136 | O75326 | |
| EEIFNCHLQRPLSSG | 111 | Q9Y6S9 | |
| GSTVDCHGLALRSVP | 36 | O94813 | |
| GAQSRSRHCEELLPG | 981 | Q9P283 | |
| TCGLSFLQEGAPHRT | 136 | A0PJX8 | |
| EGCLLNTAHVTGPEA | 1126 | Q9P2J2 | |
| CPAVLGSQRFSSGRH | 336 | Q495X7 | |
| DPSGRDLEHCLQGSV | 1046 | Q9ULM0 | |
| ECGKGFSRPSSLQAH | 451 | Q9NYT6 | |
| GSPHLSDSACLGQQR | 476 | Q17R98 | |
| GTLREPVTIDCGHNF | 21 | Q9UDY6 | |
| GKGFDCPSSLQSHER | 371 | Q9Y2A4 | |
| SGGLHCSSNAIRFVP | 931 | Q2M389 | |
| NRTHLLTCGTGAFDP | 126 | O15041 | |
| CAQPLGELTSLDAHG | 51 | Q9UMR3 | |
| TFHVSGEPSTCREVG | 81 | Q13106 | |
| VSLSAHQRSCGAPDG | 466 | Q6NUN9 | |
| PEVALSLSCGHSRGL | 3496 | Q70CQ2 | |
| RAGSPDVLRCSSQGH | 41 | Q8NDX6 | |
| TDGEQPITLSICGHS | 581 | Q8IWV8 | |
| SFSLTRVDCSGLGPH | 36 | Q8WUA8 | |
| PGTAHQRLILSDDCT | 301 | Q9BVG3 | |
| GSSLQGRCFLHDLEP | 136 | Q04912 | |
| GRCFLHDLEPQGTAV | 141 | Q04912 | |
| TVGNDHFCVSTPERR | 151 | Q5VUA4 | |
| HSLSRQNCPFLAGET | 126 | P56192 | |
| AVQGSGDTSRHCLPT | 246 | Q96RL1 | |
| DSCRPGFGKNERLHS | 276 | Q6X784 | |
| TGTRTHGSPDCDDIV | 366 | Q92563 | |
| PAFCIHNGGSDLERL | 1031 | Q15386 | |
| EAIGQLHRSLESCPG | 541 | Q9UNY4 | |
| RPSECETLGSNLGHN | 181 | Q8TF47 | |
| ERGDEHSLGCSPSNS | 1046 | Q70EL1 | |
| GRLVDTHGPFETCLL | 1356 | Q9Y493 | |
| CTEIFGGNPRFLSLH | 411 | O14978 | |
| SEREQHLGCGTPGLE | 1901 | O14686 | |
| LGCRPQTGFSDIKSH | 501 | Q05513 | |
| LGPDCTRHTTLGLLN | 96 | P50539 | |
| NSHRSLSGCPIAAAE | 566 | Q9UL68 |